In 2000 the cardiology community changed the way doctors diagnose a heart attack. A laboratory test, cardiac troponin (cTn) test, became an important tool for doctors to make this diagnosis. Over the next dozen years, many studies (including CIHR-funded studies performed within McMaster and ECRI) provided the evidence on when to measure cTn in the emergency room and what levels should be used to determine if a patient has had a heart attack.
When he was 10 years old, Hsien Seow’s mother died of cancer after struggling with the illness for four years. But not surprisingly, she wasn’t the only one who struggled — the entire family was affected. They took the end-of-life journey, with its many ups and downs, together — feeling very much alone as they navigated the system.
October 18th, 2013 marked the 10th anniversary of AGREE. It is hard to believe 10 years have passed since the release of the original AGREE Instrument.
The Hamilton Health Sciences Foundation has received a $330,000 donation to support research into developing a new model of care for cancer survivors.
New research chair focuses on novel drugs to prevent cancer
For Paola Muti, the question of how to avoid cancer is a serious one.
Officially launched as a joint McMaster University/Hamilton Health Sciences Research Institute in September 2011, the Escarpment Cancer Research Institute (ECRI) represented the coming together of a cadre of 17 clinical and health services researchers deeply committed to making a difference in the lives of cancer patients and their families.